Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

Unlocking the Antimicrobial Potential of Chilean Fungi through Integrated Functional and Genomic Approaches

Project description

Exploring the hidden world of fungi for new treatments

The rapid increase in antimicrobial resistance poses a critical threat to global health, highlighting the urgent need for discovery of new antibiotics. Historically, fungi have been the source of life-saving medicines such as penicillin, but many fungal genomes remain largely untapped. Supported by the Marie Skłodowska-Curie Actions programme, the FungalBioChile project seeks to discover novel biologically active compounds by exploring a diverse collection of understudied fungal species endemic to Chile. By combining high-throughput antimicrobial screening with modern genomic tools, the project aims to identify dormant biosynthetic gene clusters. Consequently, it will be able to induce, isolate and characterise new antimicrobial metabolites that can combat resistant pathogens.

Objective

Antimicrobial resistance (AMR) is a major global health threat, demanding innovative discovery pipelines for new bioactive molecules. Fungi represent a proven yet underexploited source of antibacterial compounds, but current approaches are hampered by high rediscovery rates and limited integration of genomic data. This project leverages an exceptional collection of 164 Chilean fungal strains preserved at the Westerdijk Institute, covering more than 50 years of sampling (1968–2022) and diverse ecosystems from the Atacama Desert to temperate rainforests. Importantly, it includes underexplored genera such as Pewenomyces, Resinogalea, Entomortierella, and Leohumicola, for which no secondary metabolites have been reported to date.
The workflow combines high-throughput antimicrobial screening with stringent dereplication to prioritize novel chemistry early on, ensuring resources are directed toward unique candidates. Active extracts will be fractionated and profiled by HRMS, while parallel genome and transcriptome sequencing will link bioactivity to biosynthetic gene clusters (BGCs). Moreover, fungi will be cultivated under elicitation conditions, to activate silent pathways and enhance metabolite discovery.
By integrating functional screening with genome-based approaches, the project will accelerate the identification of novel antibacterial molecules with potential relevance against multidrug-resistant pathogens. Beyond discovery, the results will expand our understanding of the untapped biosynthetic capacity of Chilean fungi, positioning them as a valuable resource for future natural product research and sustainable drug development.

Fields of science (EuroSciVoc)

Keywords

Programme(s)

Topic(s)

Funding Scheme

HORIZON-TMA-MSCA-PF-EF - HORIZON TMA MSCA Postdoctoral Fellowships - European Fellowships

See all projects funded under this funding scheme

Call for proposal

(opens in new window) HORIZON-MSCA-2025-PF

See all projects funded under this call

Coordinator

KONINKLIJKE NEDERLANDSE AKADEMIE VAN WETENSCHAPPEN - KNAW
Net EU contribution
€ 232 916,16
Address
KLOVENIERSBURGWAL 29 HET TRIPPENHUIS
1011 JV AMSTERDAM
Netherlands
Activity type
Research Organisations
Links
Total cost
No data